Annual Total Assets
$202.63 M
+$83.11 M+69.54%
December 31, 2024
Summary
- As of March 10, 2025, SLN annual total assets is $202.63 million, with the most recent change of +$83.11 million (+69.54%) on December 31, 2024.
- During the last 3 years, SLN annual total assets has risen by +$72.81 million (+56.08%).
- SLN annual total assets is now at all-time high.
Performance
SLN Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$202.63 M
-$24.03 M-10.60%
December 1, 2024
Summary
- As of March 10, 2025, SLN quarterly total assets is $202.63 million, with the most recent change of -$24.03 million (-10.60%) on December 1, 2024.
- Over the past year, SLN quarterly total assets has stayed the same.
- SLN quarterly total assets is now -17.43% below its all-time high of $245.40 million, reached on March 31, 2024.
Performance
SLN Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
SLN Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +69.5% | 0.0% |
| 3 y3 years | +56.1% | 0.0% |
| 5 y5 years | +235.4% | 0.0% |
SLN Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +69.5% | -17.4% | +100.3% |
| 5 y | 5-year | at high | +235.4% | -17.4% | +235.4% |
| alltime | all time | at high | +4182.8% | -17.4% | +4308.4% |
Silence Therapeutics Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $202.63 M(+69.5%) | - |
| Dec 2024 | - | $202.63 M(-10.6%) |
| Sep 2024 | - | $226.67 M(-5.0%) |
| Jun 2024 | - | $238.59 M(-2.8%) |
| Mar 2024 | - | $245.40 M(+105.3%) |
| Dec 2023 | $119.52 M(-8.1%) | $119.52 M(+0.0%) |
| Sep 2023 | - | $119.50 M(+2.2%) |
| Jun 2023 | - | $116.94 M(+0.1%) |
| Mar 2023 | - | $116.84 M(-10.2%) |
| Dec 2022 | $130.10 M(+0.2%) | $130.10 M(-6.1%) |
| Sep 2022 | - | $138.51 M(+36.9%) |
| Jun 2022 | - | $101.16 M(-11.3%) |
| Mar 2022 | - | $114.00 M(-12.2%) |
| Dec 2021 | $129.83 M(+10.8%) | $129.83 M(+4.2%) |
| Sep 2021 | - | $124.54 M(-10.7%) |
| Jun 2021 | - | $139.40 M(+19.0%) |
| Dec 2020 | $117.16 M(+93.9%) | $117.16 M(-4.9%) |
| Jun 2020 | - | $123.20 M(+103.9%) |
| Dec 2019 | $60.41 M(+22.4%) | - |
| Dec 2019 | - | $60.41 M(+58.8%) |
| Jun 2019 | - | $38.04 M(-22.9%) |
| Dec 2018 | $49.34 M(-33.6%) | - |
| Dec 2018 | - | $49.34 M(-20.7%) |
| Jun 2018 | - | $62.18 M(-16.3%) |
| Dec 2017 | $74.34 M(+8.0%) | - |
| Dec 2017 | - | $74.34 M(+11.4%) |
| Jun 2017 | - | $66.75 M(-3.0%) |
| Dec 2016 | $68.84 M(-24.5%) | - |
| Dec 2016 | - | $68.84 M(-12.6%) |
| Jun 2016 | - | $78.74 M(-13.6%) |
| Dec 2015 | $91.18 M(+96.8%) | - |
| Dec 2015 | - | $91.18 M(-7.9%) |
| Jun 2015 | - | $99.05 M(+113.8%) |
| Dec 2014 | $46.34 M(-4.1%) | - |
| Dec 2014 | - | $46.34 M(-21.5%) |
| Jun 2014 | - | $59.03 M(+22.2%) |
| Dec 2013 | $48.32 M | - |
| Dec 2013 | - | $48.32 M(-4.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2013 | - | $50.76 M(+84.0%) |
| Dec 2012 | $27.59 M(-46.8%) | - |
| Dec 2012 | - | $27.59 M(+94.2%) |
| Jun 2012 | - | $14.21 M(-72.6%) |
| Dec 2011 | $51.91 M(-0.9%) | - |
| Dec 2011 | - | $51.91 M(-11.4%) |
| Jun 2011 | - | $58.57 M(+11.8%) |
| Dec 2010 | $52.41 M(+194.8%) | - |
| Dec 2010 | - | $52.41 M(-6.5%) |
| Jun 2010 | - | $56.04 M(+215.3%) |
| Dec 2009 | $17.78 M(-15.6%) | - |
| Dec 2009 | - | $17.78 M(-14.3%) |
| Jun 2009 | - | $20.75 M(-1.4%) |
| Dec 2008 | $21.06 M(-45.5%) | - |
| Dec 2008 | - | $21.06 M(-29.6%) |
| Jun 2008 | - | $29.89 M(-22.6%) |
| Dec 2007 | $38.63 M(+17.7%) | - |
| Dec 2007 | - | $38.63 M(+30.6%) |
| Jun 2007 | - | $29.57 M(-9.9%) |
| Dec 2006 | $32.82 M(+11.1%) | - |
| Dec 2006 | - | $32.82 M(+20.0%) |
| Jun 2006 | - | $27.35 M(-7.4%) |
| Dec 2005 | $29.55 M(+382.9%) | - |
| Dec 2005 | - | $29.55 M(+542.8%) |
| Jun 2005 | - | $4.60 M(-24.9%) |
| Dec 2004 | $6.12 M(-47.2%) | - |
| Dec 2004 | - | $6.12 M(-20.0%) |
| Jun 2004 | - | $7.65 M(-34.0%) |
| Dec 2003 | $11.59 M(-15.3%) | - |
| Dec 2003 | - | $11.59 M(-3.5%) |
| Jun 2003 | - | $12.01 M |
| Dec 2002 | $13.67 M(-2.7%) | - |
| Dec 2001 | $14.05 M(-22.3%) | - |
| Dec 2000 | $18.08 M(+3.4%) | - |
| Dec 1999 | $17.49 M(+166.9%) | - |
| Dec 1998 | $6.55 M(-24.9%) | - |
| Dec 1997 | $8.72 M(-25.2%) | - |
| Dec 1996 | $11.66 M(+146.3%) | - |
| Dec 1995 | $4.73 M | - |
FAQ
- What is Silence Therapeutics annual total assets?
- What is the all time high annual total assets for Silence Therapeutics?
- What is Silence Therapeutics annual total assets year-on-year change?
- What is Silence Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for Silence Therapeutics?
- What is Silence Therapeutics quarterly total assets year-on-year change?
What is Silence Therapeutics annual total assets?
The current annual total assets of SLN is $202.63 M
What is the all time high annual total assets for Silence Therapeutics?
Silence Therapeutics all-time high annual total assets is $202.63 M
What is Silence Therapeutics annual total assets year-on-year change?
Over the past year, SLN annual total assets has changed by +$83.11 M (+69.54%)
What is Silence Therapeutics quarterly total assets?
The current quarterly total assets of SLN is $202.63 M
What is the all time high quarterly total assets for Silence Therapeutics?
Silence Therapeutics all-time high quarterly total assets is $245.40 M
What is Silence Therapeutics quarterly total assets year-on-year change?
Over the past year, SLN quarterly total assets has changed by $0.00 (0.00%)